Skip to main content

Trulieve Cannabis Corp.

corporate_fare Company Profile

Trulieve Cannabis Corp.

TRLV·NYSE·Life Sciences·CIK 0001754195

Trulieve Cannabis Corp. is a vertically integrated cannabis company and multi-state operator with operations in nine states. Headquartered in Tallahassee, Florida, the company is the largest cannabis retailer in the United States. Trulieve maintains market-leading retail operations in Arizona, Florida, Georgia, Pennsylvania, and West Virginia. The company operates in highly regulated markets, requiring expertise in cultivation, manufacturing, and retail. Trulieve has developed proficiencies in each of these functional areas. All states where Trulieve operates have programs permitting the use of cannabis products for medicinal purposes, referred to as medical cannabis. Recreational cannabis, or adult-use cannabis, is legal cannabis sold in licensed dispensaries to adults ages 21 and older. Of the states in which Trulieve operates, Arizona, Colorado, Connecticut, Maryland, and Ohio have launched programs legalizing the sale of adult-use cannabis products. Trulieve conducts its business through its owned subsidiaries, which hold licenses in the states where they operate. The company's Subordinate Voting Shares are listed on the Canadian Securities Exchange ("CSE") under the symbol "TRUL" and traded in the United States on the OTCQX Best Market ("OTCQX") under the symbol "TCNNF".

Trulieve Cannabis Corp. (NYSE:TRLV) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for TRLV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for TRLV spans 10-Q, 8-K, DEF 14A, 144.

Recent high-impact activity:

  • Trulieve 10-Q: Q3 Swings to $869K Net Income, $326.7M Cash, $403.3M Harvest Charge
  • Trulieve Posts $230M Q3 Revenue, 64% Margin, $89M Adjusted EBITDA
  • Trulieve Q2 2026: A $403M Deconsolidation Loss Obscures Resilient Medical-Only Operations
  • Trulieve Q2: $271M Revenue, $98M Adj. EBITDA, Harvest Deconsolidation Drives $406M Net Loss
  • Trulieve Cannabis Corp. Finalizes Plan to Re-domicile to Delaware, Sets Shareholder Vote

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.18B
Net Income
-$122.25M
Diluted EPS
-$0.58
Op. Cash Flow
$272.82M
Free Cash Flow
$228.63M
Gross Profit
$711.17M
Operating Income
$143.5M
Cash & Equivalents
$255.53M
Total Debt
$136.74M
Debt / Equity
0.12×
Net Margin
-10.3%
Shares Outstanding
192.31M sh
Source: 10-K · filed 2026-02-26 · accession 0001754195-26-000019

Short Interest & Short Volume

3.37 days to cover

FINRA reported short interest of 3,841,922 shares in TRLV as of the October 30, 2026 settlement, a 47.1% decrease from the prior period — about 3.4 days to cover at its recent average daily volume. On November 20, 2026, 39.3% of TRLV volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,841,922 shares as of October 30, 2026
Change vs prior period▼ 47.1%
Days to cover3.37 at avg daily volume of 1,140,524
Daily short volume (FINRA facilities)39.3% of 765,975 shares on November 20, 2026
5-day average short volume42.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with T →
$8.72 +0.46% today
52-week range · as of 2026-11-05 $4.62 – $13.28
Market cap
$1.67B
Volume
1.7M (1.2× avg)
3-mo avg 1.4M
Live data · 2026-11-22 12:39 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TRLV - Latest Insights

TRLV
Nov 05, 2026, 6:20 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.94
Real-time Price: $8.72 info
Change: -$3.22 (-27%) info
Market Cap: $1.674B info
TRLV
Nov 05, 2026, 6:15 AM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $11.94
Real-time Price: $8.72 info
Change: -$3.22 (-27%) info
Market Cap: $1.674B info
TRLV
Aug 07, 2026, 6:22 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.51
Real-time Price: $8.72 info
Change: +$0.2063 (+2%) info
Market Cap: $1.674B info
TRLV
Aug 07, 2026, 6:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.51
Real-time Price: $8.72 info
Change: +$0.2063 (+2%) info
Market Cap: $1.674B info
TRLV
Jun 25, 2026, 5:13 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $8.48
Real-time Price: $8.72 info
Change: +$0.240 (+3%) info
Market Cap: $1.674B info
TRLV
Jun 17, 2026, 9:45 AM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $9.73
Real-time Price: $8.72 info
Change: -$1.00 (-10%) info
Market Cap: $1.674B info
TRLV
Jun 12, 2026, 8:14 AM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $11.70
Real-time Price: $8.72 info
Change: -$2.98 (-25%) info
Market Cap: $1.674B info
TRLV
Jun 12, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.64
Real-time Price: $8.72 info
Change: -$2.92 (-25%) info
Market Cap: $1.674B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets